Our Services
Intelligent Clinical Trials Solutions (iCTS) is a comprehensive Clinical Trials Management company dedicated to advancing medical research.
Training
We help clinical researchers navigate complex regulatory pathways by ensuring compliance with local and global standards like NAFDAC, FDA, and ICH-GCP.
Phases
Clinical trials are conducted in distinct phases, each designed to answer specific questions about the new treatment: Phase 1 (Safety), Phase 2 (Efficacy), Phase 3 (Confirmation), and Phase 4 (Post-Market).
Regulatory Compliance & Ethical Oversight
Ensuring trials are conducted ethically and scientifically, meeting strict regulatory requirements to monitor patient health and ensure safety throughout the study.
Dual Expertise
Experience how iCTS streamlines the clinical trial process—advancing innovation with accuracy, empathy, and integrity.
Patient Recruitment & Engagement Strategies
Our team provides strategic patient recruitment services that focus on trust, community engagement, and retention.
Technology-Enabled Trial Management
At iCTS, we use technology to simplify and improve clinical trial management through digital tools that support tracking, remote monitoring, document handling, and real-time reporting, all while maintaining security and compliance.
Why partner with iCTS?
We own and operate our entire site network, meaning no third-party delays, standardized training, and a single point of accountability for your trial.
Patient Identification & Engagement
Leveraging our proprietary database of 20M+ profiles and advanced AI targeting, we consistently exceed enrollment targets up to 30% faster than industry averages.
Global Site Network
Access 250+ highly standardized, fully owned clinical research sites across North America, Europe, and APAC, ensuring consistent protocols globally.
Data Quality & Oversight
Our unified technology stack provides real-time oversight, ensuring 99.8% data accuracy and reducing source data verification timelines.
Flexible & Scalable Solutions
From traditional site-based models to fully decentralized home trials, we adapt our operational framework to suit your unique protocol requirements.
Accelerating Phase III Asthma Enrollment by 45%
See how our hybrid approach utilizing centralized screening and 12 dedicated sites delivered a fully enrolled study 4 months ahead of schedule.